Corpus Intelligence IC Memo — GEORGETOWN COMMUNITY HOSPITAL 2026-04-26 11:17 UTC
IC Memo — GEORGETOWN COMMUNITY HOSPITAL
Investment Committee Memorandum | KY | 75 beds | Grade C | EBITDA uplift $8.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GEORGETOWN COMMUNITY HOSPITAL

CCN 180101 | SCOTT, KY | 75 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

GEORGETOWN COMMUNITY HOSPITAL is a 75-bed suburban community hospital in SCOTT, KY with $118.5M in net patient revenue and a 15.1% operating margin. The hospital serves a payer mix of 19.9% Medicare, 1.1% Medicaid, and 79.0% commercial.

Thesis: Turnaround. Our ML models identify $8.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 15.1% to 22.5% (+736bps).

Net Revenue HCRIS$118.5M
Current EBITDA COMPUTED$17.9M
Operating Margin COMPUTED15.1%
Occupancy HCRIS22.5%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS20.0%
Distress Probability ML51.7%

2. Market Context & Competitive Position

114
KY Hospitals
-0.6%
State Median Margin
47
Comparable Hospitals

KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 15.1% places it above the state median. Among 47 size-comparable peers (38-150 beds), the median margin is -0.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (38-150), prioritizing same-state peers. 47 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GEORGETOWN COMMUNITY HOSPITAL (Target)KY75$118.5M15.1%
BAPTIST HEALTH LAGRANGEKY42$236.9M2.7%
ST. ELIZABETH FLORENCEKY134$212.6M8.8%
SAINT JOSEPH EASTKY138$209.5M2.6%
ST. CLAIRE MEDICAL CENTERKY100$204.5M-8.5%
HAZARD ARHKY109$200.8M-32.3%
T.J. SAMSON COMMUNITY HOSPITALKY112$189.4M-10.5%
SAINT JOSEPH LONDONKY118$173.7M-8.1%
JENNIE STUART MEDICAL CENTERKY122$165.3M-6.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.5M+210bp18mo
Cost to Collect4.5%2.5%$2.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.4M+122bp9mo
Clean Claim Rate88.0%96.0%$76K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.5M
Cost to Collect
$2.4M
Denial Rate Reduction
$2.3M
A/R Days Reduction
$1.4M
Clean Claim Rate
$76K
Total EBITDA Uplift$8.7M
Current EBITDA$17.9M
+ RCM Uplift+$8.7M
Pro Forma EBITDA$26.6M
Current Margin15.1%
Pro Forma Margin22.5%
WC Released (1x)$4.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$27.6M$205.3M7.45x49.4%
Base (11x exit)10.0x11.0x$27.6M$234.8M8.52x53.5%
Bull Case9.0x11.0x$24.8M$272.5M10.99x61.5%
Bull (12x exit)9.0x12.0x$24.8M$304.6M12.28x65.1%
Bear Case11.0x10.0x$30.3M$152.8M5.04x38.2%
Bear (11x exit)11.0x11.0x$30.3M$177.9M5.87x42.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 22.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 51.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 47 hospitals with 38-150 beds
  • Same-state prioritization (n=48)
  • Comp margins: P25=-10.7% / P50=-0.6% / P75=9.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.